Seven numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 10 other studies
the abstract, start to end
… major cardiovascular events (MACE) (RR = 0.89, 95% CI: 0.82-0.96, P = .002), acute myocardial infarction (AMI) (RR = 0.85, 95% CI: 0.74-0.99, P = .036), all-cause death (RR = 0.84, 95% CI: 0.74-0.96, P = .009), and cardiovascular death (RR = 0.77, 95% CI: 0.65-0.91, P = .002) …
… not decrease incidence of stroke (RR = 0.86, 95% CI: 0.70-1.04, P = .124).
… in placebo-controlled trials (RR = 0.89, 95% CI: 0.83-0.96, P = .004) but not in studies concerning other comparators (RR = 0.58, 95% CI: 0.29-1.16, P = .122).
← favours treatmentfavours comparator →
could be chanceCardiovascular events
RR 0.890.82–0.96
Cardiovascular events
RR 0.850.74–0.99
Cardiovascular events
RR 0.840.74–0.96
Cardiovascular events
RR 0.770.65–0.91
Cardiovascular events
RR 0.860.70–1.04
Cardiovascular events
RR 0.890.83–0.96
Cardiovascular events
RR 0.580.29–1.16
GLP-1 receptor agonistsCardiovascular events
GLP-1 receptor agonists × cardiovascular eventshelps?mixed
unlikelylikely
0.50not counted
← favours treatmentfavours comparator →
1 / 5